Massivemarkets

SEC Form 4

Evommune, Inc. (EVMN) insider trading

In the 12 months to Nov 19, 2026, 6 EVMN insiders reported open-market sales of $2.3M across 8 filings; 3 insiders bought $163.6K.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$2.3M
8 filings · 6 insiders
Open-market purchases
$163.6K
3 filings
Pre-arranged sales (10b5-1)
8 of 8
All $2.3M sold was pre-arranged

Who traded EVMN, and when

  • Purchase
  • Sale
  • Sale, pre-arranged (10b5-1)

EVMN daily close from Nov 19, 2025 to Nov 18, 2026, between $5.10 and $31.57, last $6.88. 8 sale and 3 purchase filings by 8 insiders, marked at their filing dates. Luis C. Pena, President & CEO: sold $550.7K across 2 filings, first filed Jun 3, 2026, last Jun 24, 2026. Janice Suzann Drew, Chief of Dev. Operations: sold $452.6K across 1 filing, first filed Jun 24, 2026, last Jun 24, 2026. Kyle Carver, Chief Financial Officer: sold $415.1K and bought $13.3K across 2 filings, first filed Jun 1, 2026, last Jul 10, 2026. Jeegar Pravinkumar Patel, Chief Scientific Officer: sold $412.9K across 2 filings, first filed Jun 3, 2026, last Jun 24, 2026. Gregory S. Moss, Chief Business & Legal Officer: sold $324.7K across 1 filing, first filed Jun 1, 2026, last Jun 1, 2026. Arthur S. Kirsch, Director: bought $133.0K across 1 filing, first filed Jul 8, 2026, last Jul 8, 2026. David E. Cohen, Director: sold $123.1K across 1 filing, first filed Jun 3, 2026, last Jun 3, 2026. Robert Lorne Hopfner, Director: bought $17.4K across 1 filing, first filed Dec 22, 2025, last Dec 22, 2025.

Largest mark · tap a row for others

Janice Suzann Drew · Chief of Dev. Operations

Sale $452,600

20,000 shares at $22.63 avg

Filed Jun 24, 2026 · traded Jun 22

Pre-arranged (10b5-1) · close on filing date $23.56

EVMN daily closelast $6.88

Luis C. Pena · President & CEO

$550.7K sold

Janice Suzann Drew · Chief of Dev. Operations

$452.6K sold

Kyle Carver · Chief Financial Officer

$415.1K sold$13.3K bought

Jeegar Pravinkumar Patel · Chief Scientific Officer

$412.9K sold

Gregory S. Moss · Chief Business & Legal Officer

$324.7K sold

Arthur S. Kirsch · Director

$133.0K bought

David E. Cohen · Director

$123.1K sold

Robert Lorne Hopfner · Director

$17.4K bought
One row per insider; marks sit at the SEC filing date, sized by dollar value.

Open-market trades

11 filings in the last 12 months
Other insider activity (not market trades) · 16 records
  • Option exercises6 records
  • Tax withholding6 records
  • Grants and awards4 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Pre-arranged (10b5-1)
The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.

Frequently asked questions

Has Evommune, Inc.'s CEO sold stock?

Yes. Luis C. Pena (CEO) sold 24,225 shares ($550.7K) in Jun 2026, all under a pre-arranged 10b5-1 plan.

How current is EVMN’s insider data?

These are EVMN Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

Build with AI

Track EVMN insider trades with your agent

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for EVMN every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.